Yazgan, S. C. Et Al. 2024. The Prognostic Value of Elimination Rate Constant K Score of Prostate-Specific Antigen in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel. PROSTATE INTERNATIONAL , 1.

Yazgan, S. C., Sarı, A., Bölek, H., Yekedüz, E., & Ürün, Y., (2024). The Prognostic Value of Elimination Rate Constant K Score of Prostate-Specific Antigen in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel. PROSTATE INTERNATIONAL , 1.

Yazgan, Satı Et Al. "The Prognostic Value of Elimination Rate Constant K Score of Prostate-Specific Antigen in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel," PROSTATE INTERNATIONAL , 1, 2024

Yazgan, Satı C. Et Al. "The Prognostic Value of Elimination Rate Constant K Score of Prostate-Specific Antigen in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel." PROSTATE INTERNATIONAL , pp.1, 2024

Yazgan, S. C. Et Al. (2024) . "The Prognostic Value of Elimination Rate Constant K Score of Prostate-Specific Antigen in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel." PROSTATE INTERNATIONAL , p.1.

@article{article, author={Satı Coskun Yazgan Et Al. }, title={The Prognostic Value of Elimination Rate Constant K Score of Prostate-Specific Antigen in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Docetaxel}, journal={PROSTATE INTERNATIONAL}, year=2024, pages={1} }